ProPhase Labs, Inc. Research and Development Expense
ProPhase Labs, Inc. (PRPH) reported Research and Development Expense of $107.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-19
- ProPhase Labs, Inc. research and development expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. research and development expense for the quarter ending 2025-09-30 was $6.00K, a 95.08% decline year-over-year.
- ProPhase Labs, Inc. research and development expense for the quarter ending 2025-06-30 was $4.00K, a 97.14% decline year-over-year.
- ProPhase Labs, Inc. research and development expense for the quarter ending 2025-03-31 was $97.00K, a 64.34% decline year-over-year.
- ProPhase Labs, Inc. research and development expense for fiscal 2025 was $107.00K, a 81.99% decline from fiscal 2024.
- ProPhase Labs, Inc. research and development expense for fiscal 2024 was $594.00K, a 57.63% decline from fiscal 2023.
- ProPhase Labs, Inc. research and development expense for fiscal 2023 was $1.40M, a 115.03% increase from fiscal 2022.
- ProPhase Labs, Inc. research and development expense for fiscal 2022 was $652.00K, a 25.38% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $6.00K derived: sum of 2 quarters · filed 2026-06-01 | $10.00K derived: sum of 3 quarters · filed 2026-08-19 | $107.00K 10-K · filed 2026-06-01 | ||||
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-19 | $10.00K derived: sum of 2 quarters · filed 2026-08-19 | $107.00K 10-Q · filed 2025-11-19 | $167.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $4.00K 10-Q · filed 2026-08-19 | $101.00K 10-Q · filed 2026-08-19 | $161.00K derived: sum of 3 quarters · filed 2026-08-19 | $283.00K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $97.00K 10-Q/A · filed 2026-07-09 | $157.00K derived: sum of 2 quarters · filed 2026-07-09 | $279.00K derived: sum of 3 quarters · filed 2026-07-09 | $419.00K derived: sum of 4 quarters · filed 2026-07-09 | ||||
| 2024-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $182.00K derived: sum of 2 quarters · filed 2026-06-01 | $322.00K derived: sum of 3 quarters · filed 2026-06-01 | $594.00K 10-K · filed 2026-06-01 | ||||
| 2024-09-30 | $122.00K 10-Q · filed 2025-11-19 | $262.00K derived: sum of 2 quarters · filed 2025-11-19 | $534.00K 10-Q · filed 2025-11-19 | $533.00K 10-Q · filed 2024-11-13 | $792.00K derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $140.00K 10-Q · filed 2025-08-13 | $139.00K 10-Q · filed 2024-08-14 | $412.00K 10-Q · filed 2025-08-13 | $411.00K 10-Q · filed 2024-08-14 | $670.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.10M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $272.00K 10-Q · filed 2025-05-20 | $530.00K derived: sum of 2 quarters · filed 2025-05-20 | $958.00K derived: sum of 3 quarters · filed 2025-05-20 | $1.53M derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $686.00K derived: sum of 2 quarters · filed 2025-04-01 | $1.26M derived: sum of 3 quarters · filed 2025-04-01 | $1.40M 10-K · filed 2025-04-01 | $1.42M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $428.00K 10-Q · filed 2024-11-13 | $1.00M derived: sum of 2 quarters · filed 2024-11-13 | $1.14M 10-Q · filed 2024-11-13 | $1.62M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $572.00K 10-Q · filed 2024-08-14 | $716.00K 10-Q · filed 2024-08-14 | $1.19M derived: sum of 3 quarters · filed 2024-08-14 | $1.30M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $144.00K 10-Q · filed 2024-05-10 | $622.00K derived: sum of 2 quarters · filed 2024-05-10 | $732.00K derived: sum of 3 quarters · filed 2024-05-10 | $760.00K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $588.00K derived: sum of 2 quarters · filed 2024-03-29 | $616.00K derived: sum of 3 quarters · filed 2024-03-29 | $652.00K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $110.00K 10-Q · filed 2023-11-13 | $138.00K derived: sum of 2 quarters · filed 2023-11-13 | $174.00K 10-Q · filed 2023-11-13 | $277.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $28.00K 10-Q · filed 2023-08-11 | $63.00K 10-Q · filed 2023-08-11 | $167.00K derived: sum of 3 quarters · filed 2023-08-11 | $375.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-12 | $139.00K derived: sum of 2 quarters · filed 2023-05-12 | $347.00K derived: sum of 3 quarters · filed 2023-05-12 | $440.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $312.00K derived: sum of 2 quarters · filed 2023-03-29 | $405.00K derived: sum of 3 quarters · filed 2023-03-29 | $520.00K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $208.00K 10-Q · filed 2022-11-10 | $301.00K derived: sum of 2 quarters · filed 2022-11-10 | $416.00K 10-Q · filed 2022-11-10 | $868.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $93.00K 10-Q · filed 2022-08-12 | $208.00K 10-Q · filed 2022-08-12 | $660.00K derived: sum of 3 quarters · filed 2022-08-12 | $717.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $115.00K 10-Q · filed 2022-05-13 | $567.00K derived: sum of 2 quarters · filed 2022-05-13 | $624.00K derived: sum of 3 quarters · filed 2022-05-13 | $689.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $509.00K derived: sum of 2 quarters · filed 2022-03-31 | $574.00K derived: sum of 3 quarters · filed 2022-03-31 | $633.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $57.00K 10-Q · filed 2021-11-12 | $122.00K derived: sum of 2 quarters · filed 2021-11-12 | $181.00K 10-Q · filed 2021-11-12 | $267.00K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $65.00K 10-Q · filed 2021-08-13 | $124.00K 10-Q · filed 2021-08-13 | $210.00K derived: sum of 3 quarters · filed 2021-08-13 | $267.00K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $59.00K 10-Q · filed 2021-05-14 | $145.00K derived: sum of 2 quarters · filed 2021-05-14 | $202.00K derived: sum of 3 quarters · filed 2021-05-14 | $297.00K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $143.00K derived: sum of 2 quarters · filed 2021-03-31 | $238.00K derived: sum of 3 quarters · filed 2021-03-31 | $332.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $57.00K 10-Q · filed 2020-11-19 | $152.00K derived: sum of 2 quarters · filed 2020-11-19 | $246.00K 10-Q · filed 2020-11-19 | $325.00K derived: sum of 4 quarters · filed 2020-11-19 | ||||
| 2019-06-30 | $95.00K 10-Q · filed 2020-08-11 | $189.00K 10-Q · filed 2020-08-11 | $268.00K derived: sum of 3 quarters · filed 2020-08-11 | $412.00K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $94.00K 10-Q · filed 2020-05-12 | $173.00K derived: sum of 2 quarters · filed 2020-05-12 | $317.00K derived: sum of 3 quarters · filed 2020-05-12 | $404.00K derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $223.00K derived: sum of 2 quarters · filed 2020-03-26 | $310.00K derived: sum of 3 quarters · filed 2020-03-26 | $398.00K 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $144.00K 10-Q · filed 2019-11-12 | $231.00K derived: sum of 2 quarters · filed 2019-11-12 | $319.00K 10-Q · filed 2019-11-12 | $431.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $87.00K 10-Q · filed 2019-08-12 | $174.00K 10-Q · filed 2019-08-12 | $287.00K derived: sum of 3 quarters · filed 2019-08-12 | $347.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $87.00K 10-Q · filed 2019-05-14 | $200.00K derived: sum of 2 quarters · filed 2019-05-14 | $260.00K derived: sum of 3 quarters · filed 2019-05-14 | $484.00K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $173.00K derived: sum of 2 quarters · filed 2019-03-26 | $397.00K derived: sum of 3 quarters · filed 2019-03-26 | $431.00K 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $60.00K 10-Q · filed 2018-11-14 | $284.00K derived: sum of 2 quarters · filed 2018-11-14 | $318.00K 10-Q · filed 2018-11-14 | $474.00K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $224.00K 10-Q/A · filed 2018-08-20 | $258.00K 10-Q/A · filed 2018-08-20 | $414.00K derived: sum of 3 quarters · filed 2018-08-20 | $457.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2017-03-31 | $34.00K 10-Q/A · filed 2018-08-20 | $190.00K derived: sum of 2 quarters · filed 2018-08-20 | $233.00K derived: sum of 3 quarters · filed 2018-08-20 | $354.00K derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-12-31 | $156.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $199.00K derived: sum of 2 quarters · filed 2018-08-20 | $320.00K derived: sum of 3 quarters · filed 2018-08-20 | $358.00K 10-K/A · filed 2018-08-20 | $575.00K 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $43.00K 10-Q/A · filed 2018-08-20 | $119.00K 10-Q · filed 2016-11-14 | $164.00K derived: sum of 2 quarters · filed 2018-08-20 | $202.00K 10-Q/A · filed 2018-08-20 | $374.00K 10-Q · filed 2016-11-14 | -$133.00K derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-06-30 | $121.00K 10-Q/A · filed 2018-08-20 | $169.00K 10-Q · filed 2016-08-11 | $160.00K 10-Q/A · filed 2018-08-20 | $255.00K 10-Q · filed 2016-08-11 | -$176.00K derived: sum of 3 quarters · filed 2018-08-20 | $19.00K derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-03-31 | $38.00K 10-Q/A · filed 2018-08-20 | $86.00K 10-Q · filed 2016-05-13 | -$297.00K derived: sum of 2 quarters · filed 2018-08-20 | -$102.00K derived: sum of 3 quarters · filed 2018-08-20 | $170.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2015-12-31 | -$335.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$140.00K derived: sum of 2 quarters · filed 2018-08-20 | $132.00K derived: sum of 3 quarters · filed 2018-08-20 | $340.00K 10-K/A · filed 2018-08-20 | $1.08M 10-K · filed 2016-03-29 | |||
| 2015-09-30 | $195.00K 10-Q · filed 2016-11-14 | $467.00K derived: sum of 2 quarters · filed 2016-11-14 | $675.00K 10-Q · filed 2016-11-14 | $1.09M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $272.00K 10-Q · filed 2016-08-11 | $480.00K 10-Q · filed 2016-08-11 | $895.00K derived: sum of 3 quarters · filed 2017-02-24 | $1.25M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $208.00K 10-Q · filed 2016-05-13 | $623.00K derived: sum of 2 quarters · filed 2017-02-24 | $979.00K derived: sum of 3 quarters · filed 2017-02-24 | $1.25M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $771.00K derived: sum of 2 quarters · filed 2017-02-24 | $1.04M derived: sum of 3 quarters · filed 2017-02-24 | $1.32M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $356.00K 10-Q · filed 2015-11-13 | $629.00K derived: sum of 2 quarters · filed 2015-11-13 | $907.00K 10-Q · filed 2015-11-13 | $1.15M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $273.00K 10-Q · filed 2015-08-12 | $551.00K 10-Q · filed 2015-08-12 | $789.00K derived: sum of 3 quarters · filed 2016-03-29 | $970.00K derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $278.00K 10-Q · filed 2015-05-13 | $516.00K derived: sum of 2 quarters · filed 2016-03-29 | $697.00K derived: sum of 3 quarters · filed 2016-03-29 | $913.00K derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $419.00K derived: sum of 2 quarters · filed 2016-03-29 | $635.00K derived: sum of 3 quarters · filed 2016-03-29 | $824.00K 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $181.00K 10-Q · filed 2014-11-13 | $397.00K derived: sum of 2 quarters · filed 2014-11-13 | $586.00K 10-Q · filed 2014-11-13 | $831.00K derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-06-30 | $216.00K 10-Q · filed 2014-08-12 | $404.00K 10-Q · filed 2014-08-12 | $650.00K derived: sum of 3 quarters · filed 2015-03-27 | $815.00K derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-03-31 | $188.00K 10-Q · filed 2014-05-12 | $434.00K derived: sum of 2 quarters · filed 2015-03-27 | $599.00K derived: sum of 3 quarters · filed 2015-03-27 | $1.13M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2012-12-31 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $411.00K derived: sum of 2 quarters · filed 2015-03-27 | $940.00K derived: sum of 3 quarters · filed 2015-03-27 | $1.30M 10-K · filed 2015-03-27 | ||||
| 2012-09-30 | $165.00K 10-Q · filed 2013-11-13 | $694.00K derived: sum of 2 quarters · filed 2013-11-13 | $1.05M 10-Q · filed 2013-11-13 | $1.55M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | $529.00K 10-Q · filed 2013-08-13 | $890.00K 10-Q · filed 2013-08-13 | $1.38M derived: sum of 3 quarters · filed 2014-03-27 | $1.58M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | $361.00K 10-Q · filed 2013-05-10 | $855.00K derived: sum of 2 quarters · filed 2014-03-27 | $1.05M derived: sum of 3 quarters · filed 2014-03-27 | $1.23M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $692.00K derived: sum of 2 quarters · filed 2014-03-27 | $868.00K derived: sum of 3 quarters · filed 2014-03-27 | $1.09M 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | $198.00K 10-Q · filed 2012-11-14 | $374.00K derived: sum of 2 quarters · filed 2012-11-14 | $594.00K 10-Q · filed 2012-11-14 | $675.00K derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-06-30 | $176.00K 10-Q · filed 2012-08-13 | $395.00K 10-Q · filed 2012-08-13 | $477.00K derived: sum of 3 quarters · filed 2013-03-28 | $945.00K derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-03-31 | $219.00K 10-Q · filed 2012-05-11 | $301.00K derived: sum of 2 quarters · filed 2013-03-28 | $769.00K derived: sum of 3 quarters · filed 2013-03-28 | $919.00K derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2010-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $550.00K derived: sum of 2 quarters · filed 2013-03-28 | $700.00K derived: sum of 3 quarters · filed 2013-03-28 | $794.00K 10-K · filed 2013-03-28 | ||||
| 2010-09-30 | $468.00K 10-Q · filed 2011-11-14 | $618.00K derived: sum of 2 quarters · filed 2011-11-14 | $712.00K 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $150.00K 10-Q · filed 2011-08-12 | $238.00K 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | $1.31M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |